In the last 12 months, insiders at TAKEDA PHARMACEUTICAL CO LTD ($TAK) filed 14 transactions with the SEC: 0 open-market purchases totaling $0 and 1 sales totaling $29,999,994. Net insider sentiment: net selling.
TAKEDA PHARMACEUTICAL CO LTD operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- TAKEDA PHARMACEUTICAL CO LTD (TenPercentOwner) — 1 transaction totaling $29,999,994
- Platford Giles Richard (President, IBU) — 1 transaction totaling $0
- Ricci Gabriele (Chief Data & Tech. Officer) — 1 transaction totaling $0
- Bitetti Teresa Marie (President, OBU) — 1 transaction totaling $0
- Furuta Milano (Chief Financial Officer) — 2 transactions totaling $0
View all SEC Filings for TAKEDA PHARMACEUTICAL CO LTD (TAK).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 27, 2026 | Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev. | A | American Depositary Shares | 27740 | $0.00 | 172,348.0000 | 1,557,765,596 | 19.18% | 0.00% |
| April 27, 2026 | Kim Julie So-Young | CEO - Elect | A | American Depositary Shares | 105416 | $0.00 | 430,145.0000 | 1,557,765,596 | 32.46% | 0.01% |
| April 27, 2026 | Platford Giles Richard | President, IBU | A | American Depositary Shares | 72124 | $0.00 | 297,363.0000 | 1,557,765,596 | 32.02% | 0.00% |
| April 27, 2026 | Weber Christophe Pierre | President and CEO | A | Ordinary Shares | 78900 | $0.00 | 1,014,200.0000 | 1,557,765,596 | 8.44% | 0.01% |
| April 27, 2026 | Weber Christophe Pierre | President and CEO | A | American Depositary Shares | 165370 | $0.00 | 418,803.0000 | 1,557,765,596 | 65.25% | 0.01% |
| April 27, 2026 | Weber Christophe Pierre | President and CEO | A | Tax Obligation Award | 78978 | $0.00 | 125,345.0000 | 1,557,765,596 | 170.33% | 0.01% |
| April 27, 2026 | Furuta Milano | Chief Financial Officer | A | Ordinary Shares | 7800 | $0.00 | 57,900.0000 | 1,557,765,596 | 15.57% | 0.00% |
| April 27, 2026 | Furuta Milano | Chief Financial Officer | A | Tax Obligation Award | 7814 | $0.00 | 16,619.0000 | 1,557,765,596 | 88.75% | 0.00% |
| April 27, 2026 | Plump Andrew Stewart | President, R&D | A | American Depositary Shares | 212470 | $0.00 | 1,087,879.0000 | 1,557,765,596 | 24.27% | 0.01% |
| April 27, 2026 | Ricci Gabriele | Chief Data & Tech. Officer | A | American Depositary Shares | 34994 | $0.00 | 159,126.0000 | 1,557,765,596 | 28.19% | 0.00% |
| April 27, 2026 | Bitetti Teresa Marie | President, OBU | A | American Depositary Shares | 64988 | $0.00 | 258,136.0000 | 1,557,765,596 | 33.65% | 0.00% |
| April 27, 2026 | Duprey Lauren Rusckowski | Chief Transformation Officer | A | American Depositary Shares | 59990 | $0.00 | 228,503.0000 | 1,557,765,596 | 35.60% | 0.00% |
| Jan. 24, 2024 | TAKEDA PHARMACEUTICAL CO LTD | TenPercentOwner | S | Common Stock | 3703703 | $8.10 | 3,755,583.0000 | 1,557,765,596 | 49.65% | 0.24% |
| April 17, 2023 | TAKEDA PHARMACEUTICAL CO LTD | Other | J | Series A Convertible Preferred Stock | 1000000 | $0.00 | 0.0000 | 1,557,765,596 | 100.00% | 0.06% |